---
title: "EuroPCR 2025: Myval shows promise in latest comparative studies against contemporary TAVI platforms"
date: "2025-05-28T08:39:05.000Z"
publishedDate: "28 mai 2025"
summary: "New data comparing the Myval transcatheter aortic valve implantation (TAVI) system (Meril Life Sciences) to contemporary TAVI platforms, have shown that the device continues to measure favourably against its competitor valves. One-year clinical and haemodynamic outcomes from the randomised LANDMARK trial were shared at EuroPCR 2025 (20–23 May, Paris, France)—comparing the balloon-expandable system to both [&#8230;] The post EuroPCR 2025: Myval shows promise in latest comparative studies against contemporary TAVI platforms appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/europcr-2025-myval-shows-promise-in-latest-comparative-studies-against-contemporary-tavi-platforms/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2025-05-28-europcr-2025-myval-shows-promise-in-latest-comparative-studies-against-contemporary-tavi-platforms"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2025/05/IMG_4218-scaled.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/europcr-2025-myval-shows-promise-in-latest-comparative-studies-against-contemporary-tavi-platforms/"
---

![EuroPCR 2025: Myval shows promise in latest comparative studies against contemporary TAVI platforms](https://cardiovascularnews.com/wp-content/uploads/sites/14/2025/05/IMG_4218-scaled.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/europcr-2025-myval-shows-promise-in-latest-comparative-studies-against-contemporary-tavi-platforms/*

## L’essentiel

New data comparing the Myval transcatheter aortic valve implantation (TAVI) system (Meril Life Sciences) to contemporary TAVI platforms, have shown that the device continues to measure favourably against its competitor valves. One-year clinical and haemodynamic outcomes from the randomised LANDMARK trial were shared at EuroPCR 2025 (20–23 May, Paris, France)—comparing the balloon-expandable system to both [&#8230;] The post EuroPCR 2025: Myval shows promise in latest comparative studies against contemporary TAVI platforms appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/europcr-2025-myval-shows-promise-in-latest-comparative-studies-against-contemporary-tavi-platforms/
